
OFIX — Orthofix Medical Inc
NASDAQ · Healthcare · Medical Devices
$9.43
+$0.04 (+0.43%)
Orthofix Medical Inc (OFIX) is a medical devices company listed on NASDAQ. It is led by Massimo Calafiore, based in 3451 Plano Parkway, Lewisville, TX, United States, 75056, with about 1,616 employees. Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, develops, and markets a portfolio of spine fixation and motion preservation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and provides 7D flash navigation system for spine and cranial procedures. Its Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Latest reported OFIX revenue for 2025-09-30 was $205.6M. Net income was -$22.8M. Revenue was up 1.2% from 2025-06-30 to 2025-09-30. OFIX currently screens at market cap $438.0M.
Use this OFIX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the OFIX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the OFIX SEC filings page. Lician reads the product cache first so this HTML stays unique to Orthofix Medical Inc even when a live quote feed is slow.
About Orthofix Medical Inc
Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, develops, and markets a portfolio of spine fixation and motion preservation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and provides 7D flash navigation system for spine and cranial procedures. Its Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
OFIX Key Statistics
Market Cap
$438.04M
Volume
282,058
Previous Close
$9.79
Day Range
$9.52 – $9.78
EPS
-$3.30
Revenue
$799.49M
Net Income
-$126.00M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+7.1%
Profit Margin
-15.8%
Employees
1,616
OFIX Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $799.49M | $746.64M | $460.71M | $464.48M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$126.00M | -$151.40M | -$19.75M | -$38.38M |
| EPS (Diluted) | -$3.30 | -$4.12 | -$0.98 | -$1.95 |
Total Assets
$893.29M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$83.24M
Operating Cash Flow
$25.79M
Free Cash Flow
$0.00
Orthofix Medical Inc Company Information
- President, CEO & Director
- Massimo Calafiore
- Headquarters
- 3451 Plano Parkway, Lewisville, TX, United States, 75056
- Website
- orthofix.com
- Phone
- 214 937 2000
- IPO / Founded
- 1992-04-24
- Sector
- Healthcare
- Industry
- Medical Devices